GMP Facility

The GMP facility is designed as a state-of-the-art cell and gene therapy industrialization platform, built on the foundation of the Guangdong Nanshan Institute of Pharmaceutical Innovation and Anjie Biomedical. The facility covers 4,700 m2, including more than 1,600 m2 of GMP workshops dedicated to nucleic acid, viral vector, stem cell, and immune cell manufacturing, as well as gene editing platform and full-scale quality control zone.

The facility strictly complies with international GMP standards and is equipped to support pharmaceutical research and clinical sample production from IND submission through Phase I/II trials. It is structured to deliver high-quality, reproducible, and traceable manufacturing processes across multiple therapeutic modalities.

In addition, the facility houses a dedicated QC platform equipped with advanced analytical technologies, enabling rigorous testing of nucleic acids, virus, and cell therapy products. Testing capabilities include physicochemical assays, biochemical and molecular analyses, flow cytometry, cell functionality evaluation, and comprehensive sterility and safety testing.

With modular design and large-scale manufacturing capacity, our GMP facility accelerates clinical translation of innovative therapies while meeting the highest standards of safety, compliance, and efficiency.